The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers

Pharmaceutical Research

Volumn 20, Issue 4, 2003, Pages 674-683

  Brigger, Irène ^a   Armand Lefevre, Laurence ^b   Chaminade, Pierre ^a   Besnard, Madeleine ^a   Rigaldie, Yohan ^c   Largeteau, Alain ^c   Andremont, Antoine ^a,b   Grislain, Luc ^d   Demazeau, Gérard ^c   Couvreur, Patrick ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICHAT HOSPITAL   (France)

^c Ecole Nationale Superieure de Chimie et de Physique de Bordeaux   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

High hydrostatic pressure processing; Nanoparticles; Poly(cyanoacrylate); Sterilization; Surface modifiers

Indexed keywords

DRUG CARRIER; NANOCAPSULE; NANOPARTICLE; POLY(CYANOACRYLATE); UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; DRUG STABILITY; EMULSION; HYDROSTATIC PRESSURE; INFRARED RADIATION; OSCILLATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; THERMAL ANALYSIS; ZETA POTENTIAL;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; HYDROSTATIC PRESSURE; NANOTECHNOLOGY; POLYMERS; STERILIZATION; SUSPENSIONS;

EID: 12444338480     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023267304096     Document Type: Article

References (25)

1. M. T. Peracchia, C. Vauthier, M. Popa, F. Puisieux, and P. Couvreur. Investigation of the formation of sterically stabilized poly(ethylene glycol/isobutylcyanoacrylate) nanoparticles by chemical grafting of polyethylene glycol during the polymerization of isobutyl cyanoacrylate. S. T. P. Pharma. Sciences 7:513-520 (1997).
2. K. A. Athanasiou, G. G. Niederauer, and C. Mauli Agrawal. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17:93-102 (1996).
3. P. Sommerfeld, U. Schroeder, and B. A. Sabel. Sterilization of unloaded polybutylcyanoacrylate nanoparticles. Int. J. Pharm. 164:113-118 (1998).
4. J. M. Rollot, P. Couvreur, L. Roblot-Treupel, and F. Puisieux. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules. J. Pharm. Sci. 75:361-364 (1986).
5. V. Masson, F. Maurin, H. Fessi, and J. P. Devissaguet. Influence of sterilization processes on poly(ε-caprolactone) nanospheres. Biomaterials 18:327-335 (1997).
6. E. Allémann, J. C. Leroux, R. Gurny, and E. Doelker. In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure. Pharm. Res. 10:1732-1737 (1993).
7. Y. N. Konan, R. Gurny, and E. Allémann. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharm. 233:239-252 (2002).
8. J. Y. Zheng and W. Bosch. Sterile filtration of NanoCrystal™ drug formulations. Drug Dev. Ind. Pharm. 23:1087-1093 (1997).
9. M. Fouarge, M. Dewulf, P. Couvreur, M. Roland, and H. Vranckx. Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. J. Microencapsul. 6:29-34 (1989).
10. E. Y. Wuytack, A. M. J. Diels, and C. W. Michiels. Bacterial inactivation by high-pressure homogenisation and high pressure hydrostatic pressure. Int. J. Food Microbiol. (2002).
11. J. C. Cheftel. Review: High-pressure, microbial inactivation and food preservation. Food Sci. Technol. Int. 1:75-90 (1995).
12. H. Ludwig, C. Bieler, K. Hallbauer, and W. Scigalla. Inactivation of microrganisms by hydrostatic pressure. In C. Balny, R. Hayashi, K. Heremans, and P. Masson (eds.) High Pressure and Biotechnology, Editions INSERM, Paris, 1992, pp. 67-75.
13. United States Food and Drug Administration. Kinetics of microbial inactivation for alternative food processing technologies: high pressure processing. Center for Food Safety and Applied Nutrition, June, 2002.
14. G. W. Gould. Preservation: past, present and future. Brit. Med. Bull. 56:84-96 (2000).
15. I. Brigger, P. Chaminade, D. Desmaële, M. T. Peracchia, J. d'Angelo, R. Gurny, M. Renoir, and P. Couvreur. Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology. Pharm. Res. 17:1124-1131 (2000).
16. H. Fessi, F. Puisieux, J. Ph. Devissaguet, N. Ammoury, and S. Benita. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:R1-R4 (1989).
17. R. Gurny, N. A. Peppas, D. D. Harrington, and G. S. Banker. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Develop. Ind. Pharm. 7:1-25 (1981).
18. R. H. Müller, C. Lherm, J. Herbort, and P. Couvreur. In vitro degradation of alkylcyanoacrylate nanoparticles. Biomaterials 11:590-595 (1990).
19. J. Kreuter. Poly(alkylcyanoacrylate) nanoparticles. Method Enzymol. 112:129-138 (1985).
20. P. Masson. Action de la pression hydrostatique sur les protéines: émergence de la biotechnologie des hautes pressions, applications pharamceutiques et médicales potentielles. Ann. Pharm. Fr. 57:49-55 (1999).
21. Y. Rigaldie, A. Largeteau, G. Lemagnen, D. Larrouture, R. Haller, G. Demazeau, and L. Grislain. Sterilisation of liquid and semi-solid pharmaceutical forms using high pressure technology. High Press. Res., in press.
22. A. G. Macdonald. Effects of high hydrostatic pressure on natural and artificial membranes. In C. Balny, R. Hayashi, K. Heremans, and P. Masson (eds.) High Pressure and Biotechnology, Editions INSERM, Paris, 1992, pp. 67-75.
23. J. P. P. M. Smelt. Recent advances in the microbiology of high pressure processing. Trends Food Sci. Tech. 9:152-158 (1998).
24. I. Hayakawa, T. Kanno, K. Yoshiyama, and Y. Fujio. Oscillatory compared with continuous high pressure sterilization on Bacillus stearothermophilus spores. J. Food Sci. 59:164-167 (1994).
25. B. Sojka and H. Ludwig. Effects of rapid pressure changes on the inactivation of bacillus subtilis spores. Pharm. Ind. 59:436-438 (1997).